门静脉高压性肠病——一种不该忽视的门静脉高压并发症
DOI: 10.3969/j.issn.1001-5256.2022.06.006
Portal hypertensive enteropathy: A disease that should not be ignored among the complications of portal hypertension
-
摘要: 门静脉高压性肠病虽与门静脉高压性胃病类似,但由于其内镜下表现多种多样且缺乏特异性,诊断标准并未统一,个体差异性大,患者可在相当长的时间内没有症状,临床易漏诊。根据患者病情及经治专家经验,在治疗方面主要包括对症支持治疗、药物治疗、内镜治疗以及放射性介入治疗和外科手术治疗。虽然近年来门静脉高压性肠病的内镜表现及治疗相关研究已有所报道,但临床医师对该病的诊治及预后仍缺乏应有的重视。Abstract: Although portal hypertensive enteropathy (PHE) is similar to portal hypertensive gastroenteropathy, it has various endoscopic manifestations with a lack of specificity, and there are still no unified diagnostic criteria. It is easily ignored by clinicians due to great individual differences and the absence of symptoms for quite a long period of time. Based on the patients' conditions and local expert experience, the treatment methods include symptomatic supportive treatment, pharmacotherapy, endoscopic therapy, radioactive intervention therapy, and surgical interventions. Although there have been reports on the endoscopic manifestations and treatment of PHE in recent years, the diagnosis, treatment, and prognosis of this disease should be taken seriously by clinicians.
-
Key words:
- Portal Hypertensive Enteropathy /
- Portal Hypertension /
- Diagnosis /
- Therapeutics
-
图 1 门静脉高压性小肠病内镜下表现
注:a,水肿;b,鲑鱼卵样病变;c,毛细血管扩张;d,正常对照[2]。
Figure 1. Endoscopic images of portal hypertensive small intestine
-
[1] GRACIA-SANCHO J, MARRONE G, FERNÁNDEZ-IGLESIAS A. Hepatic microcirculation and mechanisms of portal hypertension[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(4): 221-234. DOI: 10.1038/s41575-018-0097-3. [2] HIGAKI N, MATSUI H, IMAOKA H, et al. Characteristic endoscopic features of portal hypertensive enteropathy[J]. J Gastroenterol, 2008, 43(5): 327-331. DOI: 10.1007/s00535-008-2166-9. [3] ROCKEY DC. An update: portal hypertensive gastropathy and colopathy[J]. Clin Liver Dis, 2019, 23(4): 643-658. DOI: 10.1016/j.cld.2019.07.002. [4] THIRUVENGADAM R, GOSTOUT CJ. Congestive gastroenteropathy—an extension of nonvariceal upper gastrointestinal bleeding in portal hypertension[J]. Gastrointest Endosc, 1989, 35(6): 504-507. DOI: 10.1016/s0016-5107(89)72898-4. [5] BARAKAT M, MOSTAFA M, MAHRAN Z, et al. Portal hypertensive duodenopathy: clinical, endoscopic, and histopathologic profiles[J]. Am J Gastroenterol, 2007, 102(12): 2793-2802. DOI: 10.1111/j.1572-0241.2007.01536.x. [6] VIGNERI S, TERMINI R, PIRAINO A, et al. The duodenum in liver cirrhosis: endoscopic, morphological and clinical findings[J]. Endoscopy, 1991, 23(4): 210-212. DOI: 10.1055/s-2007-1010658. [7] GUPTA R, SARASWAT VA, KUMAR M, et al. Frequency and factors influencing portal hypertensive gastropathy and duodenopathy in cirrhotic portal hypertension[J]. J Gastroenterol Hepatol, 1996, 11(8): 728-733. DOI: 10.1111/j.1440-1746.1996.tb00322.x. [8] SHUDO R, YAZAKI Y, SAKURAI S, et al. Duodenal erosions, a common and distinctive feature of portal hypertensive duodenopathy[J]. Am J Gastroenterol, 2002, 97(4): 867-873. DOI: 10.1111/j.1572-0241.2002.05602.x. [9] EGEA VALENZUELA J, FERNÁNDEZ LLAMAS T, GARCÍA MARÍN AV, et al. Diagnostic and therapeutic features of small bowel involvement in portal hypertension[J]. Rev Esp Enferm Dig, 2017, 109(12): 856-862. DOI: 10.17235/reed.2017.4596/2016. [10] SAWADA K, OHTAKE T, UENO N, et al. Multiple portal hypertensive polyps of the jejunum accompanied by anemia of unknown origin[J]. Gastrointest Endosc, 2011, 73(1): 179-182. DOI: 10.1016/j.gie.2010.07.011. [11] MISRA SP, DWIVEDI M, MISRA V, et al. Ileal varices and portal hypertensive ileopathy in patients with cirrhosis and portal hypertension[J]. Gastrointest Endosc, 2004, 60(5): 778-783. DOI: 10.1016/s0016-5107(04)02049-8. [12] SAWADA K, OHTAKE T, UENO N, et al. Multiple portal hypertensive polyps of the jejunum accompanied by anemia of unknown origin[J]. Gastrointest Endosc, 2011, 73(1): 179-182. DOI: 10.1016/j.gie.2010.07.011. [13] MISRA V, MISRA SP, DWIVEDI M, et al. Histomorphometric study of portal hypertensive enteropathy[J]. Am J Clin Pathol, 1997, 108(6): 652-657. DOI: 10.1093/ajcp/108.6.652. [14] de PALMA GD, REGA M, MASONE S, et al. Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study[J]. Gastrointest Endosc, 2005, 62(4): 529-534. DOI: 10.1016/s0016-5107(05)01588-9. [15] JIANG ZN, DUAN XH, XIA L, et al. Histopathological observation of portal hypertensive enteropathy[J]. Chin J Pathol, 2018, 47: 953-954. DOI: 10.3760/cma.j.issn.0529-5807.2018.12.012.姜支农, 段晓红, 夏龙, 等. 门脉高压性肠病组织病理学观察[J]. 中华病理学杂志, 2018, 47: 953-954. DOI: 10.3760/cma.j.issn.0529-5807.2018.12.012. [16] KOZAREK RA, BOTOMAN VA, BREDFELDT JE, et al. Portal colopathy: prospective study of colonoscopy in patients with portal hypertension[J]. Gastroenterology, 1991, 101(5): 1192-1197. DOI: 10.1016/0016-5085(91)90067-u. [17] URRUNAGA NH, ROCKEY DC. Portal hypertensive gastropathy and colopathy[J]. Clin Liver Dis, 2014, 18(2): 389-406. DOI: 10.1016/j.cld.2014.01.008. [18] BRANCO JC, CARVALHO R, ALBERTO SF, et al. Long-acting octreotide is effective in the treatment of portal hypertensive colopathy[J]. Gastroenterol Hepatol, 2017, 40(8): 536-537. DOI: 10.1016/j.gastrohep.2016.10.006. [19] MISRA SP, DWIVEDI M, MISRA V, et al. Colonic changes in patients with cirrhosis and in patients with extrahepatic portal vein obstruction[J]. Endoscopy, 2005, 37(5): 454-459. DOI: 10.1055/s-2005-861252. [20] NAVEAU S, BEDOSSA P, POYNARD T, et al. Portal hypertensive colopathy. A new entity[J]. Dig Dis Sci, 1991, 36(12): 1774-1781. DOI: 10.1007/BF01296624. [21] BINI EJ, LASCARIDES CE, MICALE PL, et al. Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study[J]. Gastrointest Endosc, 2000, 52(4): 511-516. DOI: 10.1067/mge.2000.108478. [22] DIAZ-SANCHEZ A, NUÑEZ-MARTINEZ O, GONZALEZ-ASANZA C, et al. Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients[J]. World J Gastroenterol, 2009, 15(38): 4781-4787. DOI: 10.3748/wjg.15.4781. [23] YAMAKADO S, KANAZAWA H, KOBAYASHI M. Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure[J]. Intern Med, 1995, 34(3): 153-157. DOI: 10.2169/internalmedicine.34.153. [24] GUIMARÃES RA, PERAZZO H, MACHADO L, et al. Prevalence, variability, and outcomes in portal hypertensive colopathy: a study in patients with cirrhosis and paired controls[J]. Gastrointest Endosc, 2015, 82(3): 469-476. e2. DOI: 10.1016/j.gie.2015.01.036. [25] CHEN LS, LIN HC, LEE FY, et al. Portal hypertensive colopathy in patients with cirrhosis[J]. Scand J Gastroenterol, 1996, 31(5): 490-494. DOI: 10.3109/00365529609006770. [26] BRESCI G, PARISI G, CAPRIA A. Clinical relevance of colonic lesions in cirrhotic patients with portal hypertension[J]. Endoscopy, 2006, 38(8): 830-835. DOI: 10.1055/s-2006-944629. [27] GANGULY S, SARIN SK, BHATIA V, et al. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension[J]. Hepatology, 1995, 21(5): 1226-1231. [28] MISRA SP, DWIVEDI M, MISRA V. Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension[J]. Endoscopy, 1996, 28(4): 340-345. DOI: 10.1055/s-2007-1005477. [29] MISRA SP, MISRA V, DWIVEDI M. Effect of esophageal variceal sclerotherapy on hemorrhoids, anorectal varices and portal colopathy[J]. Endoscopy, 1999, 31(9): 741-744. DOI: 10.1055/s-1999-77. [30] MISRA SP, MISRA V, DWIVEDI M. Effect of esophageal variceal band ligation on hemorrhoids, anorectal varices, and portal hypertensive colopathy[J]. Endoscopy, 2002, 34(3): 195-198. DOI: 10.1055/s-2002-20290. [31] ABDELAAL UM, MORITA E, NOUDA S, et al. Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact?[J]. J Clin Biochem Nutr, 2010, 47(1): 37-44. DOI: 10.3164/jcbn.10-14. [32] MEKAROONKAMOL P, COHEN R, CHAWLA S. Portal hypertensive enteropathy[J]. World J Hepatol, 2015, 7(2): 127-138. DOI: 10.4254/wjh.v7.i2.127. [33] RONDONOTTI E, VILLA F, SIGNORELLI C, et al. Portal hypertensive enteropathy[J]. Gastrointest Endosc Clin N Am, 2006, 16(2): 277-286. DOI: 10.1016/j.giec.2006.01.019. [34] MATHUR V, KAUR G, PRAJAPAT RK, et al. Colonoscopic findings in patients of portal hypertension due to different etiologies and their correlation[J]. J Assoc Physicians India, 2021, 69(9): 11-12. [35] KHALIFA A, ROCKEY DC. Lower gastrointestinal bleeding in patients with cirrhosis-etiology and outcomes[J]. Am J Med Sci, 2020, 359(4): 206-211. DOI: 10.1016/j.amjms.2020.01.007. [36] JIMENEZ-SAENZ M, ROMERO-VAZQUEZ J, CAUNEDO-ALVAREZ A, et al. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy[J]. Dig Liver Dis, 2010, 42(3): 232-233. DOI: 10.1016/j.dld.2009.06.001. [37] KOO SM, JEONG SW, JANG JY, et al. Jejunal variceal bleeding successfully treated with percutaneous coil embolization[J]. J Korean Med Sci, 2012, 27(3): 321-324. DOI: 10.3346/jkms.2012.27.3.321. [38] HASKAL ZJ, SCOTT M, RUBIN RA, et al. Intestinal varices: treatment with the transjugular intrahepatic portosystemic shunt[J]. Radiology, 1994, 191(1): 183-187. DOI: 10.1148/radiology.191.1.8134568. [39] JEON SR, KIM JO. Capsule endoscopy for portal hypertensive enteropathy[J]. Gastroenterol Res Pract, 2016, 2016: 8501394. DOI: 10.1155/2016/8501394.